within Pharmacolibrary.Drugs.ATC.D;

model D11AH03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.01,
    Cl             = 3.3333333333333335e-05,
    adminDuration  = 600,
    adminMass      = 200 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.01,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.00385,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>D11AH03</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Cromoglicic acid, also known as cromolyn sodium, is a mast cell stabilizer used mainly for the prophylactic treatment of allergic conditions such as asthma, allergic rhinitis, and conjunctivitis. It is not a first-line therapy and its use has declined with the introduction of more effective medications, but it remains approved in several regions for specific indications.</p><h4>Pharmacokinetics</h4><p>Reported pharmacokinetics in healthy adult volunteers after oral administration.</p><h4>References</h4><ol><li><p>Joyce, P, et al., &amp; Prestidge, CA (2022). Chitosan nanoparticles facilitate improved intestinal permeation and oral pharmacokinetics of the mast cell stabiliser cromoglycate. <i>International journal of pharmaceutics</i> 612 121382–None. DOI:<a href=\"https://doi.org/10.1016/j.ijpharm.2021.121382\">10.1016/j.ijpharm.2021.121382</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/34919999/\">https://pubmed.ncbi.nlm.nih.gov/34919999</a></p></li><li><p>Zeiss, CR (1992). Intense pharmacotherapy. <i>Chest</i> 101(6 Suppl) 407S–409S. DOI:<a href=\"https://doi.org/10.1378/chest.101.6_supplement.407s\">10.1378/chest.101.6_supplement.407s</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/1591941/\">https://pubmed.ncbi.nlm.nih.gov/1591941</a></p></li><li><p>Taburet, AM, &amp; Schmit, B (1994). Pharmacokinetic optimisation of asthma treatment. <i>Clinical pharmacokinetics</i> 26(5) 396–418. DOI:<a href=\"https://doi.org/10.2165/00003088-199426050-00006\">10.2165/00003088-199426050-00006</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7914480/\">https://pubmed.ncbi.nlm.nih.gov/7914480</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end D11AH03;
